Follow Intuitive Surgical to never miss an important update.
The board of directors is growing from ten to eleven members to make room for Aaron Martin, who will join on January 1, 2027. Mr. Martin currently serves as the president of insurance at Humana. Adding an executive with deep experience in the insurance industry is a logical move for a company that relies on hospitals getting paid by insurers for robotic procedures. While this change is notable for the company's governance, it is a routine expansion and does not change the day-to-day operations of the business.
Source: 8-K filing
Leerink Partners nudged its price target up from $473 to $503 while keeping a positive rating on the stock. This move follows recent results showing that hospitals are adopting the new da Vinci 5 robot quickly and performing more surgeries than expected. Other analysts have also been raising their targets, bringing the average across firms to $485. The stock currently trades around $454, suggesting that analysts generally believe the company's lead in robotic surgery and its steady income from surgical tools justify a higher price.
Source: Leerink Partners
After Intuitive Surgical reported its October results, we cut our quality score to 4.4. We moved our rating from Buy to Watch and raised our expectations for robot placements after the company installed 546 systems in three months. We have added the cost of legal settlements and the pace of share buybacks to the specific risks we track. We also lowered our expectation for how much of each dollar in sales the company keeps as profit.
The number of surgeries performed using Intuitive’s systems grew 15 percent this quarter, a key sign that robotic-assisted surgery continues to gain ground over traditional methods. The company also placed 379 new systems in hospitals, including 110 of its latest Da Vinci 5 model. This growing base of machines is vital because it locks in recurring revenue from the specialized tools and services each surgery requires.
While the business itself is growing, the company narrowed its profit expectations for the rest of the year, partly due to costs from a recent legal settlement. For long-term owners, the core story remains intact: more machines in hospitals and more surgeons trained on the platform create a high barrier for rivals to overcome.
Source: GlobeNewsWire
Alongside its earnings, the company disclosed it has reached a settlement in an antitrust case. These cases typically involve claims that a dominant company is using its size to unfairly block competition. While the specific cost was not detailed, settling removes a legal distraction that has been hanging over the business.
Management also narrowed its forecast for how much surgical volume will grow this year. Even though the current 15 percent growth is healthy, tightening the range can sometimes signal that the company sees a slight cooling in demand or tougher comparisons ahead. For long-term owners, the main thing to watch is whether this settlement changes how the company sells its instruments and services, which are its most reliable source of profit.
Source: Barrons
Management consistently sets a bar they can clear, beating profit targets for eight straight quarters as the business outruns even the most bullish forecasts.
| Expectation | |
|---|---|
| EPS | $2.96 |
| Revenue | $3.24B |
Follow Intuitive Surgical to get the latest and most important updates.
Follow ISRG